Active08681617Private limited companySevenoaks

ERAMOL (UK) LTD

Significant control: Eramol Group Holdings Ltd (75–100%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Eramol (UK) Ltd: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Eramol (UK) Ltd sell?

Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

ERAMOL (UK) LTD is an active private limited company (company number 08681617) incorporated on 9 September 2013, registered in Sevenoaks. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest abridged accounts cover the period ending 31 December 2025, showing net assets of £5.53m and cash of £1.45m, with 44 employees on average. As abridged accounts, no profit and loss account is filed, so turnover and profit are not public.

Peer position · net assets

By net assets it sits in the top quarter of 661 comparable companies in the UK (median £265, upper quartile £89k).

02

Ownership and control

1 active · 4 other
  • Eramol Group Holdings Ltd
    corporate entity · since 1 December 2021
    • owns 75–100% of shares
    • holds 75–100% of voting rights
  • Mrs Caroline Mollison
    Individual · since 6 April 2016 · ceased 10 September 2018
    • owns 25–50% of shares
  • Mr Ka Yan Che
    Individual · since 6 April 2016 · ceased 1 December 2021
    • owns 25–50% of shares
  • Ms Sin Yee Sham
    Individual · since 6 April 2016 · ceased 10 September 2018
    • owns 25–50% of shares
  • Mr Peter Mollison
    Individual · since 6 April 2016 · ceased 1 December 2021
    • owns 25–50% of shares

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
9 September 201313 yrs ago
Next accounts due
30 September 2027in 340 days
Confirmation statement due
23 September 2027in 333 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 21100
Manufacture of basic pharmaceutical products
Accounts type
Unaudited Abridged
Size band
SmallCompanies Act thresholds
05

Financials

5 periods on record · latest ending 31 December 2025
Net assets
£5.53m
Not reported the period before
Cash at bank
£1.45m
Not reported the period before
Turnover
Not disclosed
Employees
44
Not reported the period before
Net assets
£5.53m
Cash at bank
£1.45m
Average employees
44
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 December 2025£5.53m£1.45m£1.16m£277k——44
1 January 2025———————
31 December 2024£5.58m£2.68m£1.67m£760k——40
1 January 2024———————
31 December 2023£4.68m£2.99m£1.73m£932k——39
Current ratio9.92Current assets ÷ creditors within one year
Cash per employee£33kCash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets above zeroNet assets £5,526,911 at 31 December 2025
  • Current assets at least 1.5× creditors within one yearCurrent ratio 9.92
  • Cash at bank of £50,000 or moreCash £1,449,534
  • Three or more accounting periods on record5 periods on record
  • Incorporated five or more years agoIncorporated 9 September 2013

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Next accounts duein 340 days
  2. Confirmation statement duein 333 days
  3. Accounts period endNet assets £5.53m · abridged accounts
  4. Accounts period end
  5. Accounts period endNet assets £5.58m · abridged accounts
  6. Accounts period end
  7. Accounts period endNet assets £4.68m · abridged accounts
  8. Incorporated
08

Similar companies in Kent

Same activity (manufacture of basic pharmaceutical products), closest in incorporation date
09

Reminders for ERAMOL (UK) LTD

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.